The revised IMSD renewal proposal from Vanderbilt University is designed to help increase the number of disadvantaged minorities entering careers in science. We have completely designed our proposal to focus exclusively on support and mentoring for those students who are matriculated in our graduate programs. As in the original application for the IMSD, the approach envisaged is one which facilitates the students'development into outstanding research scientists by providing support at a time when many minority students feel stressed and challenged by what is often a highly unfamiliar new environment in terms of the educational institution, the learning strategies, and the heavy dependence on laboratory instruction and the scientific literature. In this proposal we will build upon our previous experience to add a number of dramatically new strategies to support our students, especially in the critical first two years of graduate study. This proposal will continue to support and enhance our activities to recruit and support the developing careers of minority students. Specifically, it will allow us to continue to facilitate our efforts in the following areas: (1) maintaining the number of minority students on campus through aggressive recruiting, (2) providing the support for dramatically increased and highly focused mentoring, (3) allowing us to make a major investment in supporting the developing careers of such students during the graduate education phase. As outlined in the progress report, we believe that we have made considerable gains in all of these areas, and we hope to continue what has been a successful program, while not being unaware that improvements can always be made.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Education Projects (R25)
Project #
5R25GM062459-07
Application #
7569355
Study Section
Special Emphasis Panel (ZGM1-MBRS-8 (IM))
Program Officer
Zlotnik, Hinda
Project Start
2000-10-01
Project End
2011-01-31
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
7
Fiscal Year
2009
Total Cost
$517,133
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Williams, Michelle M; Lee, Linus; Werfel, Thomas et al. (2018) Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell Death Dis 9:21
Seferovic, Maxim D; Beamish, Christine A; Mosser, Rockann E et al. (2018) Increases in bioactive lipids accompany early metabolic changes associated with ?-cell expansion in response to short-term high fat diet. Am J Physiol Endocrinol Metab :
Flores, Bianca; Schornak, Cara C; Delpire, Eric (2018) A role for KCC3 in maintaining cell volume of peripheral nerve fibers. Neurochem Int :
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719
Shonesy, Brian C; Parrish, Walker P; Haddad, Hala K et al. (2018) Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior. Biol Psychiatry 84:304-315
Steiner, Bradley D; Eberly, Allison R; Hurst, Melanie N et al. (2018) Evidence of Cross-Regulation in Two Closely Related Pyruvate-Sensing Systems in Uropathogenic Escherichia coli. J Membr Biol 251:65-74
Lizama, Britney N; Palubinsky, Amy M; McLaughlin, BethAnn (2018) Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues. Neurochem Int 117:139-155
Infante Lara, Lorena; Fenner, Sabine; Ratcliffe, Steven et al. (2018) Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences. Nucleic Acids Res 46:2218-2233
Elion, David L; Jacobson, Max E; Hicks, Donna J et al. (2018) Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers. Cancer Res 78:6183-6195

Showing the most recent 10 out of 244 publications